Log in

OTCMKTS:PRTXProtalex Stock Price, Forecast & News

0.00 (0.00 %)
(As of 07/3/2020 04:00 PM ET)
Today's Range
Now: $0.01
50-Day Range N/A
52-Week Range
Now: $0.01
Volume200 shs
Average Volume2,060 shs
Market Capitalization$236,650.00
P/E RatioN/A
Dividend YieldN/A
Protalex, Inc. focuses on the development of biopharmaceutical drugs for treating autoimmune and inflammatory diseases in the United States. The company targets a range of autoimmune diseases, such as rheumatoid arthritis (RA), immune thrombocytopenia (ITP), psoriasis, myasthenia gravis, chronic idiopathic demyelinating polyneuropathy, and pemphigus. Its lead product candidate is PRTX-100, an immunomodulatory therapy, a highly-purified form of staphylococcal protein A, which is in Phase I/II open-label, dose-escalating study for the treatment of patients with persistent/chronic ITP; and Phase 1b clinical trial for the treatment of RA on methotrexate or leflunomide. The company was founded in 1999 and is based in Florham Park, New Jersey.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.72 out of 5 stars

Industry, Sector and Symbol

Industry Commercial physical research
Current SymbolOTCMKTS:PRTX
Previous SymbolNASDAQ:PRTX



Sales & Book Value

Annual SalesN/A



Market Cap$236,650.00
Next Earnings DateN/A
OptionableNot Optionable

Receive PRTX News and Ratings via Email

Sign-up to receive the latest news and ratings for PRTX and its competitors with MarketBeat's FREE daily newsletter.

Protalex (OTCMKTS:PRTX) Frequently Asked Questions

How has Protalex's stock been impacted by COVID-19 (Coronavirus)?

Protalex's stock was trading at $0.0025 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, PRTX stock has increased by 100.0% and is now trading at $0.0050. View which stocks have been most impacted by Coronavirus.

How were Protalex's earnings last quarter?

Protalex Inc. (OTCMKTS:PRTX) issued its earnings results on Friday, April, 13th. The company reported ($0.06) earnings per share (EPS) for the quarter. View Protalex's earnings history.

Has Protalex been receiving favorable news coverage?

News headlines about PRTX stock have trended somewhat negative on Saturday, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Protalex earned a media sentiment score of -1.8 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news about Protalex.

Who are some of Protalex's key competitors?

What other stocks do shareholders of Protalex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Protalex investors own include Boeing (BA), Caterpillar (CAT), Enterprise Products Partners (EPD), Eros International (EROS), Global Payments (GPN), Intuitive Surgical (ISRG), AT&T (T), VirTra Systems (VTSI), ANSYS (ANSS) and Baker Hughes (BKR).

Who are Protalex's key executives?

Protalex's management team includes the following people:
  • Mr. Arnold P. Kling Esq., Pres & Director (Age 61)
  • Dr. William E. Gannon Jr., Chief Medical Officer & Member of Scientific Advisory Board
  • Dr. John Bruce Lundy McClain M.D., Medical Director & Member of Scientific Advisory Board
  • Dr. Michelle Catalina Ph.D., Director of Preclinical Studies & Member of Scientific Advisory Board

What is Protalex's stock symbol?

Protalex trades on the OTCMKTS under the ticker symbol "PRTX."

How do I buy shares of Protalex?

Shares of PRTX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Protalex's stock price today?

One share of PRTX stock can currently be purchased for approximately $0.01.

How big of a company is Protalex?

Protalex has a market capitalization of $236,650.00. Protalex employs 2 workers across the globe.

What is Protalex's official website?

The official website for Protalex is www.protalex.com.

How can I contact Protalex?

Protalex's mailing address is 131 COLUMBIA TURNPIKE SUITE 1, FLORHAM PARK NJ, 07932. The company can be reached via phone at 215-862-9720 or via email at [email protected]

This page was last updated on 7/4/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.